Jan. 20 at 6:55 PM
$AVVOF The funniest part? In financial circles, ColoAlert gets lumped into “micro-cap biotech.” In clinical circles, it gets discussed as “PCR+mRNA stool screening assay with competitive adenoma detection.” Two different universes, same product 🌌